Biomotion Sciences. Ordinary Shares SLXN 深 沪
已收盘 05-22 16:00:00 美东时间
0.50
+0.025
+5.26%
华盛通- 最 高0.51
- 今 开0.4303
- 成交量 264.59万股
- 最 低 0.4263
- 昨 收 0.475
- 总市值 209.50万
- 52周最高 22.36
- 市盈率 静 --
- 换手率 63.15%
- 52周最低 0.231
- 委 比 -95.08%
- 总股本 419.00万
- 历史最高 627.75
- 量 比 0.04
- 振 幅 17.62%
- 历史最低 0.231
- 每 手 1
- 风险率 4.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Silexion Therapeutics (NASDAQ:SLXN) shares moved upwards by 147.2% to ...
05-20 20:06
Silexion Therapeutics Q1 EPS $(0.85) Beats $(1.29) Estimate
Silexion Therapeutics (NASDAQ:SLXN) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.29) by 34.11 percent. This is a 77.86 percent increase over losses of $(3.84) per share
05-16 06:58
Silexion Therapeutics Initiates Good Manufacturing Practice Clinical Batch Manufacturing Of SIL204 In Support Of Planned Upcoming Phase 2/3 Clinical Trial In LAPC
Silexion advances toward Phase 2/3 trial in KRAS-driven pancreatic cancer, as SIL204 begins GMP clinical manufacturing in collaboration with global leading manufacturing partner Catalent at its European center of
05-13 20:04
Silexion Therapeutics shares are trading lower. The company announced the submission of a Clinical Trial Application to Germany for its planned Phase 2/3 clinical trial of its lead, siRNA product candidate, SIL204.
Silexion Therapeutics shares are trading lower. The company announced the submi...
04-29 03:20
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 63.0% to $0...
04-25 01:05
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Psyence Biomedical (NASDAQ:PBM) shares increased by 63.4% to $9.59 dur...
04-17 05:05
Silexion Secures Regulatory Approval To Launch Phase 2/3 Trials Of SIL204 RNAi Therapy Targeting KRAS-Driven Pancreatic Cancer
Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting highly prevalent
03-24 20:38
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular s...
03-21 01:06
Silexion Therapeutics Q4 EPS $(1.40) Misses $(1.07) Estimate
Silexion Therapeutics (NASDAQ:SLXN) reported quarterly losses of $(1.40) per share which missed the analyst consensus estimate of $(1.07) by 30.84 percent. This is a 100.66 percent decrease over earnings of $213.60 per
03-18 05:16
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
